Skip to main content
Erschienen in: Journal of Neurology 4/2011

01.04.2011 | Original Communication

Management of punding in Parkinson’s disease: an open-label prospective study

verfasst von: A. Fasano, L. Ricciardi, M. Pettorruso, A. R. Bentivoglio

Erschienen in: Journal of Neurology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Punding, a peculiar stereotyped behavior characterized by intense fascination with complex, excessive, non-goal-oriented, repetitive activities, is a quite rare condition complicating Parkinson’s disease (PD). It is triggered by dopaminergic therapy and could have a strong impact on patient quality of life. No study has specifically investigated medical management of this condition, and only a few anecdotal reports have provided therapeutic hints. Given the suggested similarities to drug-induced dyskinesias, we have previously suggested a multistep algorithm for management of punding. We conducted a prospective open-label study on ten PD punders aimed at testing its validity. In two cases, reduction of levodopa therapy was efficacious; amantadine was effective in controlling punding in four cases; in the remaining cases, quetiapine was employed, with mild efficacy in two cases.
Literatur
1.
Zurück zum Zitat Evans AH, Katzenschlager R, Paviour D, O’Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405PubMedCrossRef Evans AH, Katzenschlager R, Paviour D, O’Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405PubMedCrossRef
2.
Zurück zum Zitat Fasano A, Petrovic I (2010) Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry 15:560–573PubMedCrossRef Fasano A, Petrovic I (2010) Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry 15:560–573PubMedCrossRef
3.
Zurück zum Zitat Rylander G (1972) Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 75:203–212PubMed Rylander G (1972) Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 75:203–212PubMed
4.
Zurück zum Zitat Fasano A, Barra A, Nicosia P, Rinaldi F, Bria P, Bentivoglio AR, Tonioni F (2008) Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding. Drug Alcohol Depend 96:178–182PubMedCrossRef Fasano A, Barra A, Nicosia P, Rinaldi F, Bria P, Bentivoglio AR, Tonioni F (2008) Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding. Drug Alcohol Depend 96:178–182PubMedCrossRef
7.
Zurück zum Zitat (2002) Amantadine and other antiglutamate agents: management of Parkinson’s disease. Mov Disord 17 (Suppl 4):13–22 (2002) Amantadine and other antiglutamate agents: management of Parkinson’s disease. Mov Disord 17 (Suppl 4):13–22
8.
Zurück zum Zitat Kashihara K, Imamura T (2008) Amantadine may reverse punding in Parkinson’s disease—observation in a patient. Mov Disord 23:129–130PubMedCrossRef Kashihara K, Imamura T (2008) Amantadine may reverse punding in Parkinson’s disease—observation in a patient. Mov Disord 23:129–130PubMedCrossRef
9.
Zurück zum Zitat Jankovic J (2005) Motor fluctuations and dyskinesias in Parkinson’s disease: clinical manifestations. Mov Disord 20 (Suppl 11):11–16 Jankovic J (2005) Motor fluctuations and dyskinesias in Parkinson’s disease: clinical manifestations. Mov Disord 20 (Suppl 11):11–16
10.
Zurück zum Zitat Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ (2006) Punding and dyskinesias. Mov Disord 21:2214–2217PubMedCrossRef Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ (2006) Punding and dyskinesias. Mov Disord 21:2214–2217PubMedCrossRef
11.
Zurück zum Zitat Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39PubMedCrossRef Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39PubMedCrossRef
12.
Zurück zum Zitat Aubert I, Guigoni C, Hakansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E (2005) Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 57:17–26PubMedCrossRef Aubert I, Guigoni C, Hakansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E (2005) Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 57:17–26PubMedCrossRef
13.
Zurück zum Zitat Kimber TE, Thompson PD, Kiley MA (2008) Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson’s disease. J Clin Neurosci 15:205–208PubMedCrossRef Kimber TE, Thompson PD, Kiley MA (2008) Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson’s disease. J Clin Neurosci 15:205–208PubMedCrossRef
14.
Zurück zum Zitat Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561–572PubMedCrossRef Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561–572PubMedCrossRef
15.
Zurück zum Zitat Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M (2010) Pathological gambling in PD is reduced by amantadine. Ann Neurol (in press) Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M (2010) Pathological gambling in PD is reduced by amantadine. Ann Neurol (in press)
16.
Zurück zum Zitat Fasano A, Elia AE, Soleti F, Guidubaldi A, Bentivoglio AR (2006) Punding and computer addiction in Parkinson’s disease. Mov Disord 21:1217–1218PubMedCrossRef Fasano A, Elia AE, Soleti F, Guidubaldi A, Bentivoglio AR (2006) Punding and computer addiction in Parkinson’s disease. Mov Disord 21:1217–1218PubMedCrossRef
17.
Zurück zum Zitat Miwa H, Morita S, Nakanishi I, Kondo T (2004) Stereotyped behaviors or punding after quetiapine administration in Parkinson’s disease. Parkinsonism Relat Disord 10:177–180PubMedCrossRef Miwa H, Morita S, Nakanishi I, Kondo T (2004) Stereotyped behaviors or punding after quetiapine administration in Parkinson’s disease. Parkinsonism Relat Disord 10:177–180PubMedCrossRef
18.
Zurück zum Zitat Durif F, Vidailhet M, Assal F, Roche C, Bonnet AM, Agid Y (1997) Low-dose clozapine improves dyskinesias in Parkinson’s disease. Neurology 48:658–662PubMed Durif F, Vidailhet M, Assal F, Roche C, Bonnet AM, Agid Y (1997) Low-dose clozapine improves dyskinesias in Parkinson’s disease. Neurology 48:658–662PubMed
19.
Zurück zum Zitat Fasano A, Pettorruso M, Ricciardi L, Conte G, Bentivoglio AR (2010) Punding in Parkinson’s disease: the impact of patient’s awareness on diagnosis. Mov Disord 25:1297–1299PubMedCrossRef Fasano A, Pettorruso M, Ricciardi L, Conte G, Bentivoglio AR (2010) Punding in Parkinson’s disease: the impact of patient’s awareness on diagnosis. Mov Disord 25:1297–1299PubMedCrossRef
Metadaten
Titel
Management of punding in Parkinson’s disease: an open-label prospective study
verfasst von
A. Fasano
L. Ricciardi
M. Pettorruso
A. R. Bentivoglio
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 4/2011
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-010-5817-8

Weitere Artikel der Ausgabe 4/2011

Journal of Neurology 4/2011 Zur Ausgabe

Pioneers in Neurology

Gustaf Retzius (1842–1919)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.